Matches 1 - 50 out of 259 1 2 3 4 5 6 >


Match Document Document Title
DE202017007052U1 lipid-lowering agents  
A pharmaceutical composition based on vitamins for regulating lipid metabolism, characterized in that the vitamins include at least folic acid and vitamin B12 or physiologically acceptable...
DE102017115496A1 Licorice root extract Solubilisate  
To provide a formulation for licorice extract products, in particular for a hydrophobic solution of glabridin, for example glavonoid, which has improved bioavailability over previously...
DE102017105036A1 Agent for use in the treatment of dyslipidemia  
The invention relates to an agent for use in the prophylaxis or treatment of dyslipidemia, in particular for the treatment of excessive LDL values, which contains propionic acid or a...
DE102016014603A1 Synthetic ayahuasca  
According to the invention, two or more of the active ingredients contained in ayahuasca (extract from parts of the plants Banisteriopsis caapi and Psychotria viridis and / or Diplopterys...
DE102016105369A1 Product, in particular food additive, feed or animal feed additive and process for its production  
The invention is based on a product, in particular a food additive, a feed and / or an animal feed additive, for supplying at least one molecule binding to a vitamin D receptor, in particular a...
DE102017204379A1 Preparation method of a water-soluble ginkobate extract and water-soluble ginkobate extract  
The present invention relates to the technical field of a preparation of traditional Chinese medicine, in particular to a preparation method of a water-soluble ginkoblate extract and a...
DE102016001672A1 A process for the preparation of a beverage  
A process for preparing a health-promoting beverage comprising the steps of: providing of the necessary natural plant raw materials (5) provide lemon and ginger, preferably pretreating the raw...
DE202017003762U1 Organic Aronia birch sap  
Aronia bark juice characterized in that the aronia bark juice consists of a mixture of aronia and birch juice.
DE112014006651T5 Pharmaceutical composition and its use for controlling blood fats and body weight of a human body  
The invention provides a composition of traditional Chinese medicine for controlling blood fats and / or body weight including Poria and Paeoniae Radix Alba, etc. The composition of traditional...
DE102015214644A1 ZUSAMMENSETZUNG ZUR BEHANDLUNG VON ERHÖHTEN CHOLESTEROL-, CORTISOL- ODER TRIGLYZERID- WERTEN  
Die Erfindung betrifft eine Zusammensetzung zur Prophylaxe oder Behandlung von krankhaft erhöhten Werten von Gesamtcholesterol und/oder LDL-Cholesterol und/oder Cortisol und/oder Triglyzeriden im...
DE202016105601U1 Erfrischungsgetränk  
Erfrischungsgetränk, welches in ein in Wasser gelöstes Gewürz sowie gegebenenfalls weitere Zusätze enthält, dadurch gekennzeichnet, dass das Wasser CO2-haltig ist.
DE212015000033U1 Therapeutic astaxanthin and phospholipid  
Dietary supplement composition formulated in an amount effective to promote the maintenance of cardiovascular health, including astaxanthin and a mixture of a phospholipidreichen roe extract and...
DE102015214641A1 Composition with acid and isoquinoline alkaloid  
The invention relates to a method for preparing a composition, the method comprising: - providing (402) at least one Isochinolinalkaloids; - Determining (404) an amount of at least one...
DE102015214637A1 Apparatus for generating an aerosol containing alkaloids  
The invention relates to a method comprising generating (304, 314) aerosol, wherein the aerosol is comprised of particulates, which include at least an isoquinoline alkaloid. The aerosol is...
DE202015003548U1 Whole egg preparation  
This present product relates to the field of foods, dietary supplements, nutraceuticals and pharmaceutical preparations, especially for prevention, alleviation or treatment of lipoproteinaemia and...
DE202008018562U1 Antigen binding proteins against proprotein convertase subtilisin Kexin Type 9 (PCSK9)  
A monoclonal antibody or fragment thereof that competes for binding to PCSK9 with: (A) an antibody comprising a variable heavy chain region of the amino acid sequence shown in SEQ ID NO: 49 set...
DE202014010499U1 Targeting human PCSK9 cholesterol treatment  
Antibody or antibody fragment for use in reducing blood cholesterol or the maintenance of a previously reduced cholesterol levels in a need thereof humans, wherein the antibody comprises a VH...
DE202014005450U1 lactose drugs  
Lactose medicament containing dry extract of artichoke leaves.
DE202015002932U1 Wu Dan Tablet for lowering blood fat  
Herbal composition with a mixture of extracts of Salvia miltiorrhiza Bge., Schisandra chinenesis (Turcz.) Baill., Schisandra sphenanthera Rehd. et Wils., Panax quinquefolium, Panax notoginseng,...
DE69831673C5 USE OF EXEDINEN AND THEIR ANTAGONISTS TO REDUCE THE food intake  
Use of an exendin or an exendin agonist selected from exendin-3, exendin-4, exendin-4 (1-30), Exendin-4- (1-30) amide, exendin-4 (1-28) - amide, 14Leu, 25Phe exendin-4 amide, 14Leu, 25Phe...
DE202014101921U1 Herbal composition for lowering blood fat  
Herbal composition with a mixture of extracts of Salvia miltiorrhiza Bge., Schisandra chinenesis (Turcz.) Baill., Schisandra sphenanthera Rehd. et Wils, Panax quinquefolium, Panax notoginseng,...
DE202014101180U1 Composition for lowering blood pressure, blood fat levels and blood sugar levels  
Composition suitable for lowering blood pressure, blood fat levels and blood sugar levels, comprising at least one ingredient selected from the group consisting of lotus root powder, tapioca,...
DE112012001540T5 Drug compound for the control of blood glucose, blood lipids and weight  
The invention provides a composition / health food composition comprising licorice extract prepared which are made of alcohol-soluble and water Radix Glycyrrhizae extracts and wolfberry. The...
DE112011100657T5 AMINE POLYMERS FOR USE AS bile acid sequestrant  
The present invention provides cross-linked amine polymers prepared, which are effective in binding and removing bile salts from the gastrointestinal tract. This bile acid sequestrant polymer or...
DE102010030688A1 Substituted dicyanopyridines and their use  
The present application relates to novel substituted dicyanopyridines, processes for their preparation, their use for the treatment and / or prevention of diseases and their use for producing...
DE102010025725A1 Preparation of an extract from Cinnamomum osmophloeum Kaneh leaves, useful e.g. for treating dyslipidemia, comprises extracting Cinnamomum osmophloeum Kaneh leaves in hot water  
Preparation of an extract from Cinnamomum osmophloeumKaneh leaves comprises: extracting Cinnamomum osmophloeumKaneh leaves in hot water at 80-100[deg] C, preferably 95-100[deg] C. Independent...
DE102010028365A1 Use of a phospholipid-containing composition for removing subcutaneous accumulations of fat  
The invention described herein relates to the use of an aqueous composition containing at least one phospholipid, at least one glycyrrhizinic acid or salts of glycyrrhizic acid for the preparation...
DE102010015123A1 New benzylamidic diphenylazetidinone compounds, useful for treating lipid disorders, hyperlipidemia, atherosclerotic manifestations or insulin resistance, and for reducing serum cholesterol levels  
Benzylamidic diphenylazetidinone compounds (I) and their salts, are new. Benzylamidic diphenylazetidinone compounds of formula (I) and their salts, are new. X : 1-30C, preferably 2-10C alkylene,...
DE102010012232A1 New imidazole useful in pharmaceutical preparation e.g. for prevention or treatment of cancer diseases, pathological effects of alcohol misuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases  
Imidazole (I), is new. Imidazole of formula (I) and its salt, are new. n : 7-14; R1 : H, halo, 1-6C alkyl, 3-8C cycloalkyl or aryl; R2 : H, halo, 1-6C alkyl or 3-8C cycloalkyl; and R3 : H, halo,...
DE69224660C5 MEANS FOR MODULATION OF PROCESS BY RETINOID RECEPTORS AND ENSURE USEFUL LINKS  
Use of at least one compound according to one of the following structures A and I to VII: STRUCTURE A wherein the unsaturated bond between the carbon atoms C9 and C10 a cis-configuration, and one...
DE102007054497B3 New crystalline hydrate form of dodecanedioic acid 4-((2S,3R)-3-((S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl)-2-(4-methoxy-phenyl)-4-oxo-azetidin-1-yl)-benzylamide ((2S,3R,4R,5R)-pentahydroxy-hexyl)-amide useful e.g. to treat hyperlipidemia  
Crystalline dodecanedioic acid 4-[(2S,3R)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-2-(4 -methoxy-phenyl)-4-oxo-azetidin-1-yl]-benzylamide ((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxy-hexyl)-amide (A)...
DE60019555C5 2-OXY-BENZOXAZINONDERIVATE FOR TREATING OBESITY  
Use of a compound formula (II): or a pharmaceutically acceptable / n salt, ester or amide thereof, in the manufacture of a medicament for the treatment of conditions which require the inhibition...
DE102007063671A1 New crystalline Diphenylazetidinonhydrate, pharmaceutical compositions containing them and their use  
The invention relates to crystalline hydrates of the formula I wherein n has a value from 0.5 to 1.8. The compound is suitable as a Hypolipidämikum.
DE60226044T2 CRYSTALLINE FORMS OF fluvastatin sodium  
Novel crystalline forms of Fluvastatin sodium hydrates were found, referred to hereinafter as polymorphic Forms C, D, E and F. Furthermore, the present invention is directed to processes for the...
DE102007051339A1 Use of an aliphatic or aromatic hydrocarbon compound for manufacturing a preparation to prevent or treat dyslipidemia  
Use of an aliphatic or aromatic hydrocarbon compound (I) or its salts for manufacturing a preparation to prevent or treat dyslipidemia, is claimed. Use of an aliphatic or aromatic hydrocarbon...
DE102007051338A1 Use of substituted glycerin derivatives for producing pharmaceutical preparation to prevent or treat isolated and/or combined dyslipidemia, hypertriglyceridemia and/or hypercholesterolemia, and for treating e.g. Parkinson's disease  
Use of substituted glycerin derivatives (I) or their salts for producing a pharmaceutical preparation to prevent or treat isolated and/or combined dyslipidemia, hypertriglyceridemia and/or...
DE102007040798A1 Herb mixture, useful e.g. to slow the aging process, comprises e.g. Crocus sativus, Elettaria cardamomum, Cinnamomum zeylanicum, Hedychium spicatum, Terminalia chebula, Trichosanthes dioica, Coleus forskolin and Berberis aristata  
Herb mixture comprises at least two of the components: e.g. Crocus sativus; Elettaria cardamomum; Cinnamomum zeylanicum; Hedychium spicatum; Terminalia chebula; Trichosanthes dioica; Coleus...
DE60132178T2 CRISTALLI SALTS OF 7-I4 (4-fluorophenyl) -6-ISOPROPYL-2-iMETHYL (methylsulfonyl) AMINO PYRIMIDIN-5-YL - (3R, 5S) -3,5-dihydroxyhept-6-enoic  
The invention relates to crystalline salts of the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfon yl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid, as well as...
DE102007021403B4 Whole egg preparation  
process for producing a whole egg preparation comprising the steps of: i) Mixing whole egg with fennel oil, and ii) sublimation of the mixture for obtaining a whole egg granules, in which the...
DE102007021403A1 Whole-egg preparation manufacturing for use in pharmaceutical formulation for medicine for treating lipoproteinaemia and controlled delivering of fennel oil ingredient to patient's transport system, involves mixing whole-egg with fennel oil  
Whole-egg preparation manufacturing involves mixing whole-egg with fennel oil, and sublimating the mixture for obtaining whole-egg granules. An electric field is exposed to the obtained mixture...
DE102007015701A1 New pharmaceutical compositions for lipolysis and processes for their preparation  
The Invention relates to a composition, particularly a pharmaceutical Composition preferably subcutaneous itself to particular Application and / or injection, for purposes of lipolysis is, wherein...
DE102007004781A1 Use of guanidinoacetic acid (salts) for the preparation of a beneficial agent  
It the use of guanidinoacetic acid and / or their Salts for producing a composition for improving brain function, bone growth and bone mineralization, to improve of cartilage growth, mitigate the...
DE102006053637B4 Last fluoro-substituted 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of the formula I, which mean X NH; R1 (C1-C6) Alkyl; R4 F; R4 'H, F; R2, R2 ', R3, R3', R5, R5 'independently of one another H, F, Cl, Br, I, OH, - (CH2) -OH, CH2F, CHF2, CF3, NO2, N3,...
DE102006053637A1 New fluorine-substituted 1,4-benzothiepine-1,1-dioxide, a process for their production, medicaments containing these compounds and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053636A1 New substituted with cyclohexyl 1,4-Benzothiepin 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053636B4 New with cyclohexyl substituted 1,4-Benzothiepin-1,1-dioxide derivatives and their use  
compounds of formula I, which mean X NH; R1 (C1-C4) Alkyl; R2 ', R3 ', R4', R5 ', R6' H; R2, R3, R4, R5, R6 independently OH, O- (C1-C6) Alkyl, OSO3H, NH2, NH- (C1-C6) -alkyl, N ((C1-C6) Alkyl)2...
DE102006053635A1 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The connection is suitable for. B. as hypolipidemic agents.
DE102006053635B4 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of formula and the pharmaceutically acceptable salts thereof.
DE202007004776U1 New pharmaceutical compositions for lipolysis  
Composition, in particular pharmaceutical composition, preferably for the particular subcutaneous application and / or injection, for purposes of lipolysis, wherein the composition in combination...
DE102006048530A1 Preparations for oral ingestion (II)  
Proposed are preparations for oral administration containing(A) sterols or sterol esters and(B) Hoodia extracts or available from the Steroidglycoside.

Matches 1 - 50 out of 259 1 2 3 4 5 6 >